Professor Mary M. Reilly is a distinguished academic and clinician serving as Professor of Neurology in the Department of Neuromuscular Diseases at University College London's Queen Square Institute of Neurology. She is also a consultant neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. Her academic appointments include: Professor of Neurology, University College London, Department of Neuromuscular Diseases Head of the Division of Clinical Neurology, UCL Queen Square Institute of Neurology Lead of the peripheral nerve clinical and research group Professor Reilly's research focuses on inherited neuropathies, with particular emphasis on Charcot-Marie-Tooth disease (CMT) and hereditary transthyretin amyloidosis (hTTRA). Her work spans the entire translational pipeline, from gene identification and pathogenetic studies through natural history studies and outcome measure development to clinical trials. She approaches her research with a patient-centered perspective, with questions arising directly from clinical encounters. Her extensive publication record demonstrates consistent contributions to understanding various forms of Charcot-Marie-Tooth disease, amyloid neuropathies, and other inherited peripheral nerve disorders. Her research employs diverse methodologies including genomic analysis, biomarker development, imaging techniques, and international collaborative studies to advance understanding and treatment of these conditions. Professor Reilly has received significant recognition for her work: Elected Fellow of the Academy of Medical Sciences (2020) Awarded Fellow of the European Academy of Neurology (2023) Past President of the Association of British Neurologists (ABN) Past President of the British Peripheral Nerve Society (BPNS) Past President of the international Peripheral Nerve Society (PNS) Current chair of the Guarantors of Brain Professor Reilly has made substantial contributions to education and mentorship in the field. As Director of Training in the inherited neuropathy consortium (INC), she developed and runs an international inherited neuropathy fellowship scheme since 2009, with 14 fellows completed. She established and directed an international fellowship program through the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNDM) between 2019-2024, connecting institutions across UK, Brazil, India, South Africa, Zambia and Turkey. She also successfully ran the MRC Neuromuscular PhD programme between 2008 and 2018, mentoring 39 students. She leads the MRC Centre for Neuromuscular Diseases Biobank London, which plays a crucial role in advancing research on rare and neuromuscular diseases through the collection and analysis of biological samples.
